Radiation InjuriesRadiation DosageAntineoplastic Combined Chemotherapy ProtocolsRadiation, IonizingDose-Response Relationship, RadiationCombined Modality TherapyRadiotherapyRadiation ToleranceRadiotherapy DosageChemotherapy, AdjuvantRadiationRadiation OncologyRadiation ProtectionRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedRadiation MonitoringRadiotherapy, AdjuvantDose FractionationTreatment OutcomeRadiation PneumonitisRadiotherapy Planning, Computer-AssistedBrachytherapyCisplatinAntineoplastic AgentsNeoplasm StagingNeoplasm Recurrence, LocalRadiometryNeoplasms, Radiation-InducedRadiation Injuries, ExperimentalDisease-Free SurvivalRadiosurgeryRadiation-Sensitizing AgentsSurvival AnalysisBreast NeoplasmsBrain NeoplasmsCranial IrradiationSurvival RateGamma RaysDoxorubicinCosmic RadiationCyclophosphamideRadiotherapy, Computer-AssistedPrognosisHead and Neck NeoplasmsNeoadjuvant TherapyNeoplasmsParticle AcceleratorsRadiotherapy, Image-GuidedLung NeoplasmsFollow-Up StudiesRadiotherapy, High-EnergyRadiation-Protective AgentsRadiodermatitisBackground RadiationChemoradiotherapyTime FactorsCarcinoma, Squamous CellAdenocarcinomaEtoposideOrgans at RiskDrug Administration ScheduleTomography, X-Ray ComputedCobalt RadioisotopesUltraviolet RaysRadiation EffectsHodgkin DiseaseCarboplatinCarcinoma, Non-Small-Cell LungVinblastineDacarbazineRetrospective StudiesMastectomy, SegmentalActuarial AnalysisProstatic NeoplasmsPaclitaxelBleomycinRadiobiologyMethotrexateSalvage TherapyX-RaysNeoplasm MetastasisAntineoplastic Agents, AlkylatingSarcomaTumor BurdenLymphatic IrradiationNeoplasms, Second PrimaryAcute Radiation SyndromeKaplan-Meier EstimateRectal NeoplasmsGlioblastomaProspective StudiesMastectomyAntimetabolites, AntineoplasticDeoxycytidineClinical Trials as TopicInduction ChemotherapyNasopharyngeal NeoplasmsCell Line, TumorLeukemia, Radiation-InducedCerebellar Neoplasms